Ind-Swift
Ind-Swift Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Ind-Swift Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Ind-Swift Ltd trades at a P/E of 1.31×.
Valuation
Profitability
Growth
Financial Health
Ind-Swift Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Ind-Swift Ltd, switchable between annual and quarterly views, consolidated or standalone.
| Period | 2018 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue from Operations | 271 | 411 | 502 | 515 |
| Other Income | 10 | 12 | 58 | 48 |
| Total Income | 281 | 423 | 560 | 563 |
| Cost of Goods Sold (COGS) | 154 | 218 | 281 | 260 |
| Gross Profit | 116 | 193 | 221 | 255 |
| +Operating Expenses | 110 | 151 | 173 | 232 |
| EBITDA | 6 | 42 | 49 | 23 |
| +Non-Operating Expenses | 14 | 149 | 90 | 343 |
| Profit Before Tax (PBT) | -53 | 26 | 16 | 288 |
| +Tax Expense | — | — | — | 4 |
| Profit After Tax (PAT) | -50 | 26 | 14 | 283 |
| Earnings Per Share (EPS) | -9.31 | 4.81 | 2.63 | 52.33 |
| Diluted Shares Outstanding (Nos.) | 5 | 5 | 5 | 5 |
| +Additional Disclosures | 464 | 665 | 825 | 820 |
| Sales Growth % | — | 51.89 | 22.21 | 2.59 |
| YoY Sales Growth % | — | — | 22.21 | 2.59 |
| Material Cost % | 46 | 47 | 41 | 44 |
| Employee Cost % | 18 | 17 | 16 | 18 |
| Other Cost % | 23 | 20 | 19 | 27 |
| OPM % | 2 | 10 | 10 | 4 |
| Tax % | — | — | — | 2 |
| Profit Growth % | — | — | -45.34 | 1,891.74 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | -0.00 | 0.00 | 0.00 | -0.00 |
| Additional Fields | -28 | 13 | 21 | -1 |
Ind-Swift segment analysis: revenue and profit mix.
Disclosed business segments at Ind-Swift with their share of revenue and profit, switchable between consolidated and standalone reporting.
Ind-Swift discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Ind-Swift Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Ind-Swift Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
What you're getting.
No strengths or opportunities on record.
What can break it.
No weaknesses or threats on record.
What would change my mind.
Trim if P/E re-rates above 2. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Ind-Swift Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Ind-Swift Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Ind-Swift Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Ind-Swift Ltd — derived from the live tape, not yesterday's close.
Ind-Swift Ltd last traded at ₹15.76 with an intraday range of ₹15.15–₹17.82 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹15.76| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 22.68 | +6.92 | +43.89% |
| R3 | 20.01 | +4.25 | +26.95% |
| R2 | 18.91 | +3.15 | +20.01% |
| R1 | 17.34 | +1.58 | +10.00% |
| PIVOT | 16.24 | 0.48 | 3.07% |
| CURRENT | 15.76 | — | — |
| S1 | 9.33 | -6.43 | -40.82% |
| S2 | 12.00 | -3.76 | -23.88% |
| S3 | 13.57 | -2.19 | -13.87% |
| S4 | 14.67 | -1.09 | -6.94% |
INDSWFTLTD is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ~
Trading Above opening range, showing Bullishness
Ind-Swift Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Ind-Swift Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Ind-Swift Ltd stood at 29.4% of traded volume, against a 20-day average of 57.6%.
Ind-Swift announcements: results, concalls, ratings, M&A.
Filings Ind-Swift sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Ind-Swift files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 13 documents below.
Suspension of Trading
Members of the Exchange are hereby informed that the trading in equity shares of Ind-Swift Limited shall be suspended w.e.f. August 14, 2025 (i.e.,…
Record Date
Ind-Swift Limited has informed the Exchange that Record date for the purpose of Merger is 14-Aug-2025.
Scheme of Arrangement
Ind-Swift Limited has informed the Exchange about Scheme of Arrangement
Amalgamation/Merger
Ind-Swift Limited has informed the Exchange about Amalgamation/Merger
Resignation
Ind-Swift Limited has informed the Exchange regarding Resignation of Mr Puneet Khurana as Company Secretary & Compliance Officer of the company…
Ind-Swift dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Ind-Swift has declared, sequenced by announce and record date.
Ind-Swift corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Ind-Swift Ltd: business, sector, key facts.
What Ind-Swift Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Ind-Swift Ltd is a listed Indian equity, listed as NSE: INDSWFTLTD, BSE: 524652.
Ind-Swift Limited is a pharmaceutical company based in Chandigarh, India, established in 1983. Its core business revolves around the development, manufacturing, and distribution of a wide range of pharmaceutical products. This encompasses finished dosage forms, active pharmaceutical ingredients (APIs), and herbal formulations catering to diverse therapeutic areas.
The company's product portfolio is extensive and covers numerous therapeutic segments. These include, but are not limited to, ENT (ear, nose, and throat), dentistry, anti-infective treatments, cardio-diabetic medications, and orthopedic therapies. Specific branded products include Zoxiclav, Glypar, Olmiswif, and several others marketed under the Ind-Swift brand or related names. Beyond these specialized areas, Ind-Swift also offers a significant line of generic medications across various therapeutic categories like gynecology, pediatrics, and dermatology.
Further diversifying its offerings, Ind-Swift provides a selection of Ayurvedic products, reflecting a commitment to traditional Indian medicine. The company’s therapeutic range is incredibly broad, encompassing antibiotics, anti-cold remedies, nutraceuticals, anti-diarrheals, anti-malarials, antidepressants, cardiology medications, diabetology treatments, anti-allergics, neurological and oncology products. This demonstrates a significant presence across numerous key areas within the pharmaceutical market.
In addition to its direct sales and distribution, Ind-Swift actively engages in contract research and manufacturing services for other pharmaceutical companies. The company also leverages international markets, exporting its products and licensing its formulations to various countries, including those in Europe, Australia, Canada, South Africa, and Russia. This global reach underlines Ind-Swift's ambition and market position as a significant player in the pharmaceutical industry.
Questions investors ask about Ind-Swift Ltd (INDSWFTLTD).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Ind-Swift Ltd (INDSWFTLTD)?
The current share price of Ind-Swift Ltd (INDSWFTLTD) is ₹15.76. Today, the stock has gained by ₹0.91 (6.13%), trading in a range of ₹15.15 to ₹17.82. The stock opened at ₹15.16 with a trading volume of 6,45,158 shares.
02Is Ind-Swift Ltd stock a good investment for long-term?
Ind-Swift Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹0 crores, P/E ratio of 1.31, ROE of 0.00%, and ROCE of 13.40%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Ind-Swift Ltd stock?
The 52-week high price of Ind-Swift Ltd (INDSWFTLTD) is ₹19.9, while the 52-week low is ₹14.71. Currently trading at ₹15.76, the stock is 20.2% away from its 52-week low and 20.8% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Ind-Swift Ltd stock at the current price?
Whether to buy Ind-Swift Ltd stock at ₹15.76 depends on multiple factors. The stock is currently trading with a P/E ratio of 1.31 and P/B ratio of 0.00. Today's performance shows a gain of 6.13%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Ind-Swift Ltd and when is the next dividend?
Ind-Swift Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹15.76, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Ind-Swift Ltd?
Ind-Swift Ltd's key financial metrics include: P/E Ratio: 1.31, P/B Ratio: 0.00, ROE: 0.00%, ROCE: 13.40%, Dividend Yield: 0.00%, EPS: ₹0.00, Book Value: ₹-122, and Debt-to-Equity: 0.00. The company's market cap stands at ₹0 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Ind-Swift Ltd stock performing today in the market?
Ind-Swift Ltd stock opened at ₹15.16 and is currently trading at ₹15.76, showing a gain of ₹0.91 (6.13%). The intraday high is ₹17.82 and low is ₹15.15. The trading volume stands at 6,45,158 shares, indicating moderate market participation today.
08What is the P/E ratio of Ind-Swift Ltd and what does it indicate?
Ind-Swift Ltd has a Price-to-Earnings (P/E) ratio of 1.31, which means investors are willing to pay ₹1.31 for every ₹1 of earnings. With an EPS of ₹0.00, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Ind-Swift Ltd (INDSWFTLTD) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- AHCL (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy